Nicholas Macleod
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data.
Journal: BMJ open
Published: February 02, 2026
The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP and albumin in patients with advanced lung cancer.
Journal: BMC cancer
Published: October 15, 2024
CT Derived Measurement of Body Composition: Observations from a Comparative Analysis of Patients with Colorectal and Lung Cancer.
Journal: Nutrition and cancer
Published: August 24, 2024
Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols.
Journal: Radiation oncology (London, England)
Published: March 15, 2024
The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer.
Journal: Clinical and translational radiation oncology
Published: May 24, 2022
Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
Journal: Clinical nutrition ESPEN
Published: July 29, 2020
The relationship between 18F-FDG-PETCT-derived tumour metabolic activity, nutritional risk, body composition, systemic inflammation and survival in patients with lung cancer.
Journal: Scientific reports
Published: April 21, 2020
Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
Journal: The British journal of radiology
Published: January 24, 2020
Pain management in patients with malignant mesothelioma: challenges and solutions.
Journal: Lung Cancer (Auckland, N.Z.)
Published: May 01, 2019
Safety and feasibility of prostate stereotactic ablative radiotherapy using multimodality imaging and flattening filter free.
Journal: The British journal of radiology
Published: January 18, 2018
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.
Journal: Clinical and translational radiation oncology
Published: October 13, 2017
Last Updated: 09/26/2026